Where does Biosense Webster, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Biosense Webster, Inc. ranks #3,697 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Biosense Webster, Inc. hold?

Biosense Webster, Inc. holds 98 US utility patents granted between 2015 and 2024, spanning 14 technology areas.

What is Biosense Webster, Inc.'s Innovation Score?

Biosense Webster, Inc. has an Innovation Score of 44.1 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Biosense Webster, Inc. focus on?

Biosense Webster, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 93 patents. Grants appear in 14 CPC subclasses total.

Is Biosense Webster, Inc.'s patent grant rate increasing or decreasing?

Biosense Webster, Inc.'s recent grant velocity is -74% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Biosense Webster, Inc.'s patents?

Biosense Webster, Inc.'s patents average 18.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Biosense Webster, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Biosense Webster, Inc.

USPTO PatentsView assignee record - 98 granted patents across 14 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Biosense ranks #3,697 of 49,997 tracked US assignees by granted-patent volume, with 98 patents across 14 technology areas.

#3,697
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.1/100): 18.6
avg claims per patent: -74%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3697 · US Corporation #3,697 · 98 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 98 grants
TOP-DECILE #3,697/49,997
PHOTO-FINISH Adient Luxembourg…
CPC-FOCUS A61B · 14 areas
INNOV-PAR 44.1/100
CLAIMS-RICH 18.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -74% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Adient Luxembourg Holding S.a.r.l. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Biosense Webster · this assignee

44
HangZhou HaiCun… · near

44
Mitac Computing… · near

44
Arcturus Therapeutics · near

44
PolyOne · near

44
3D Lighting… · lowest

7

What this shows Biosense's Innovation Score is 44.1/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Biosense's grants concentrate

Biosense Webster, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 94.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (24 grants) versus a trough of 2 in 2021. By volume, Biosense sits between Veeva Systems Inc. and Flir Systems AB.

Biosense's three-year grant acceleration

From 2019–2021 to 2022–2024, Biosense Webster, Inc. moved from 21 to 12 grants (0.57x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Veeva Systems

99
Wheel Group Holdi…

99
Aichi Steel

98
Adient Luxembourg…

98
CTS

98
Curevac

98
Delta T

98
Flir Systems AB

98
Biosense Webster ◀

98

What this shows Biosense holds 98 patents at rank #3,697, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Biosense

By rank, the assignees closest to #3,697 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Biosense's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Biosense, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Mitac Computing Technology Corporation 44 HangZhou HaiCun Information Technology Co., Ltd. 44 PolyOne Corporation 44 Arcturus Therapeutics, Inc. 44

Similar claim depth

Nearest assignees by average claims per patent (18.6 here).

Shanghai United Imaging Intelligence Co., Ltd. 18.6 avg Nabors Drilling Technologies USA, Inc. 18.6 avg Kba-notasys SA 18.6 avg R.J. Reynolds Tobacco Company 18.6 avg

Biosense's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Biosense Webster, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	24	24.5%
2016	15	15.3%
2017	15	15.3%
2018	11	11.2%
2019	13	13.3%
2020	6	6.1%
2021	2	2.0%
2022	7	7.1%
2024	5	5.1%

Which technologies does Biosense Webster, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 93

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 61

Y10T - Technical Subjects Covered BY Former US Classification 9

G06T - Image Data Processing OR Generation, IN General 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 3

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 3

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 2

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 2

C08L - Compositions OF Macromolecular Compounds 2

G06V - Image OR Video Recognition OR Understanding 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

G01V - GEOPHYSICS; Gravitational MEASUREMENTS; Detecting Masses OR OBJECTS; Tags 1

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#3,697

of 49,997 tracked assignees

Innovation Score

44.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Biosense Webster, Inc.'s patent record in context - here's where to go next.

Biosense Webster, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 94.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,697 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Biosense Webster, Inc. against Veeva Systems Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.